Chlamydophila pneumoniae

According to WHO, respiratory tract infections are one of the main causes of sickness rate and mortality both at infancy and at older ages. About 70 % of these infections affect the upper respiratory tract and middle ear region.

Diagnosis and treatment of respiratory infections remain the focus of attention among both therapists and pediatricians since these infections account for over 90 % of all outpatients’ complaints, especially during autumn and winter seasons.

According to the statistics, C. pneumoniae is the causative agent of about 5-15 % of the community-acquired pneumonia cases. Based on the clinical presentation only, it is often impossible to make a clear diagnose. Therefore, special emphasis should be given to laboratory diagnostics to allow for establishing the infection etiology and making diagnostics at early stages of the disease.
Laboratory diagnostics with using microbiological techniques is complicated. The comparison between sensitivity of microscopical method and PCR indicates that the frequency of pathogen detectability by microscopic examination is 10-12 % and by PCR at least 98 % respectively. With meeting the requirements for culture technique, the sensitivity for chlamydia diagnostics is 60-80 %, while PCR shows the sensitivity at least 95-98 %.

The Chlamydophila pneumoniae Real-Time PCR Detection Kit is in vitro DNA test, which is intended for the specific identification of Chlamydophila pneumoniae in human biological samples.

Sample: sputum, bronchoalveolar lavage, scrapes and washouts from nasal and oral pharynx

DNA extraction: PREP-NA, PREP-GS, PREP-RAPID extraction kits

Certification: RUO